Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)

NCT05170269 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Congenital Cytomegalovirus Infection

Interventions

DRUG: BT097

Sponsor

Biotest